Jane Street’s Zosano Pharma Corporation ZSAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-974
Closed -$16K 11440
2021
Q4
$16K Buy
+974
New +$20.6K ﹤0.01% 9848
2021
Q3
Sell
-627
Closed -$21K 11138
2021
Q2
$21K Sell
627
-128
-17% -$4.13K ﹤0.01% 9640
2021
Q1
$33K Buy
+755
New +$31.6K ﹤0.01% 8917
2020
Q4
Sell
-552
Closed -$31K 8395
2020
Q3
$31K Buy
+552
New +$25.7K ﹤0.01% 6988
2020
Q1
Sell
-384
Closed -$20K 6244
2019
Q4
$20K Buy
+384
New +$23.7K ﹤0.01% 4952
2019
Q3
Sell
-311
Closed -$36K 6009
2019
Q2
$36K Buy
+311
New +$36.8K ﹤0.01% 4986
2017
Q2
Sell
-38
Closed -$51K 5048
2017
Q1
$51K Buy
+38
New +$45.9K ﹤0.01% 4013

Other funds holding ZSAN

Jane Street's ZSAN Position: Q1 2022 in Review

Jane Street sold out of Zosano Pharma Corporation (ZSAN) in Q1 2022, closing a stake of 974 shares — an estimated $16K sold.

Jane Street first reported a position in ZSAN in Q1 2017 and held it in 7 quarters. The position peaked at $51K in Q1 2017. 30 funds tracked by Wall St. Rank hold ZSAN as of Q1 2022.

  • Jane Street reported no remaining Zosano Pharma Corporation position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 974 Zosano Pharma Corporation shares in Q1 2022, an estimated $16K.
  • Jane Street first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 7 quarters.
  • Jane Street's Zosano Pharma Corporation position peaked at $51K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.